102 related articles for article (PubMed ID: 21255956)
1. Apolipoprotein A-I therapy promise, challenges, and disappointment.
Davidson MH
J Am Coll Cardiol; 2011 Mar; 57(9):1120-1. PubMed ID: 21255956
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial.
Nicholls SJ; Gordon A; Johansson J; Wolski K; Ballantyne CM; Kastelein JJ; Taylor A; Borgman M; Nissen SE
J Am Coll Cardiol; 2011 Mar; 57(9):1111-9. PubMed ID: 21255957
[TBL] [Abstract][Full Text] [Related]
3. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ
Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535
[TBL] [Abstract][Full Text] [Related]
4. Effect of fenofibrate on Chlamydia pneumoniae antibody levels in patients with coronary artery disease.
Mark L; Katona A; Marki-Zay J
Am J Cardiol; 2002 Jan; 89(1):111. PubMed ID: 11779542
[No Abstract] [Full Text] [Related]
5. RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo.
Bailey D; Jahagirdar R; Gordon A; Hafiane A; Campbell S; Chatur S; Wagner GS; Hansen HC; Chiacchia FS; Johansson J; Krimbou L; Wong NC; Genest J
J Am Coll Cardiol; 2010 Jun; 55(23):2580-9. PubMed ID: 20513599
[TBL] [Abstract][Full Text] [Related]
6. [Aggressive statin therapy reduces the progression of atherosclerosis-- DMW15/2005].
Taut V
Dtsch Med Wochenschr; 2006 Mar; 131(9):460; author reply 460. PubMed ID: 16493575
[No Abstract] [Full Text] [Related]
7. Atherosclerosis: targeting endogenous apo A-I--a new approach for raising HDL.
Shah PK
Nat Rev Cardiol; 2011 Apr; 8(4):187-8. PubMed ID: 21364534
[No Abstract] [Full Text] [Related]
8. [Pronounced lowering of low density cholesterol combined with elevation of high density cholesterol was associated with reduction of coronary atheroma. Results of ASTEROID trial].
Gratsianskiĭ NA
Kardiologiia; 2006; 46(5):71-3. PubMed ID: 16858362
[No Abstract] [Full Text] [Related]
9. Cholesterol, lipids, and statins.
Ballantyne CM
Tex Heart Inst J; 2005; 32(3):378-9. PubMed ID: 16392223
[TBL] [Abstract][Full Text] [Related]
10. Statins and regression of coronary atherosclerosis.
Athyros VG; Kakafika A; Karagiannis A; Mikhailidis DP
JAMA; 2007 May; 297(20):2197; author reply 2197. PubMed ID: 17519408
[No Abstract] [Full Text] [Related]
11. Trial clouds use of niacin with a statin.
Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
[No Abstract] [Full Text] [Related]
12. Effect of pioglitazone and its combination with statins in coronary artery disease patients with hyperinsulinemia.
Mehta A; Shah U; Parikh K; Chag M; Baxi H; Chandarana A; Naik A; Naik A; Shah K; Goyal R
Can J Physiol Pharmacol; 2007 Jun; 85(6):628-33. PubMed ID: 17823625
[TBL] [Abstract][Full Text] [Related]
13. HDL cholesterol and residual risk of first cardiovascular events.
Saely CH; Vonbank A; Drexel H
Lancet; 2010 Nov; 376(9754):1738; author reply 1738-9. PubMed ID: 21093648
[No Abstract] [Full Text] [Related]
14. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.
Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H;
J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789
[TBL] [Abstract][Full Text] [Related]
15. High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor.
Fukutomi T; Takeda Y; Suzuki S; Ito T; Joh T; Itoh M
Int J Cardiol; 2010 Jun; 141(3):320-2. PubMed ID: 19138801
[TBL] [Abstract][Full Text] [Related]
16. Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
Seshasai SR; Ray KK
Future Cardiol; 2009 Mar; 5(2):129-39. PubMed ID: 19371188
[TBL] [Abstract][Full Text] [Related]
17. Lipoproteins and cardiovascular risk.
Ravnskov U
Lancet; 2003 Jun; 361(9373):1988-9; author reply 1989. PubMed ID: 12801767
[No Abstract] [Full Text] [Related]
18. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
19. Optimal lipids, statins, and dementia.
Lavie CJ; Milani RV
J Am Coll Cardiol; 2005 Mar; 45(6):963-4; author reply 964-5. PubMed ID: 15766838
[No Abstract] [Full Text] [Related]
20. Med could reverse arterial blockages.
Health News; 2006 Jul; 12(7):13. PubMed ID: 16858860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
